Anti-DNA Ligase IV antibody (ab26039)
Publishing research using ab26039? Please let us know so that we can cite the reference in this datasheet.
ab26039 has been referenced in 4 publications.
- Dean JL et al. Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition. J Biol Chem 287:29075-87 (2012). WB ; Human . PubMed: 22733811
- Slupianek A et al. BCR/ABL stimulates WRN to promote survival and genomic instability. Cancer Res 71:842-51 (2011). WB ; Mouse . PubMed: 21123451
- Salton M et al. Involvement of matrin 3 and SFPQ/NONO in the DNA damage response. Cell Cycle 9: (2010). PubMed: 20421735
- Chen X et al. Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair. Cancer Res 68:3169-77 (2008). IP ; Human . PubMed: 18451142